Release Date: 27/02/15 09:21 Summary: Maiden Dividend and 2014 Financial Year Results Price Sensitive: No Download Document 58.54KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%